MEDI6469

BIOLOGICAL2 trials

Sponsors

Providence Health & Services

Conditions

Colorectal NeoplasmsLiver MetastasesLung MetastasesMetastatic Breast Cancer

Phase 1

Stereotactic Body Radiation and Monoclonal Antibody to OX40 (MEDI6469) in Breast Cancer Patients With Metastatic Lesions

CompletedNCT01862900

Providence Health & ServicesLiver Metastases, Lung Metastases, Metastatic Breast Cancer

Start: 2012-04-27End: 2018-08-15Updated: 2019-03-21

Anti-OX40 Antibody (MEDI6469) in Patients With Metastatic Colorectal Cancer

TerminatedNCT02559024

Providence Health & ServicesColorectal Neoplasms

Start: 2016-03-14End: 2018-10-31Updated: 2022-02-14